Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians

MRSA Colonization Clinical Trial

Official title:

The Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Nasal Carriage Among Resident Physicians

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00929435
• Other study ID #: 14684
• Status: Terminated
• Phase: N/A
• First received: June 24, 2009
• Last updated: April 5, 2012
• Start date: June 2009
• Est. completion date: January 2012

Study information

• Verified date: April 2012
• Source: University of Oklahoma
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

One hundred new residents will be recruited prior to the start of residency and followed prospectively for a year. Monthly nasal swabs will be performed to identify colonization with methicillin resistant staphylococcus aureus (MRSA).The proportion of study subjects colonized with MRSA at the end of 1 year will be calculated.

Description:

This is a prospective observational study looking at the incidence of MRSA colonization. New residents will be monitored every month with nasal swabs.We would like to elucidate factors responsible for MRSA colonization in healthcare workers.We would like to see if health care workers who are colonized spontaneously cleared MRSA and if there was any factors involved.

Nasal swabs will be plated on the spot by trained individuals and the plates then incubated for 48 hours. Plates will be read by microbiologist after incubation.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 30
• Est. completion date: January 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 25 Years to 65 Years

Eligibility

Inclusion Criteria:

• Study subjects will be newly appointed residents at the OU medical center

Exclusion Criteria:

• Previous MRSA infection

• Current use of mupirocin

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• MRSA Colonization
• Staphylococcal Infections

Locations

Country	Name	City	State
United States	Oklahoma University health science center	Oklahoma City	Oklahoma

Sponsors (1)

Lead Sponsor	Collaborator
University of Oklahoma

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To detect an increase in MRSA nasal carriage rate among newly appointed residents after 1 year of regular patient contact.		1 year	No